Cargando…
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. In the absence of human cases of smallpox, new treatments must be tested for efficacy in animal models. Previously, we demonstrated the e...
Autores principales: | Rice, Amanda D., Adams, Mathew M., Wallace, Greg, Burrage, Andrew M., Lindsey, Scott F., Smith, Andrew J., Swetnam, Daniele, Manning, Brandi R., Gray, Stacey A., Lampert, Bernhard, Foster, Scott, Lanier, Randall, Robertson, Alice, Painter, George, Moyer, Richard W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046869/ https://www.ncbi.nlm.nih.gov/pubmed/21373379 http://dx.doi.org/10.3390/v3010047 |
Ejemplares similares
-
Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
por: Rice, Amanda D., et al.
Publicado: (2011) -
Development of CMX001 for the Treatment of Poxvirus Infections
por: Lanier, Randall, et al.
Publicado: (2010) -
Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model
por: Parker, Scott, et al.
Publicado: (2008) -
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014) -
Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246
por: Quenelle, Debra C., et al.
Publicado: (2010)